Product correctly added to cart.

discount label
PL 017
View 3D

Biosynth logo

PL 017

CAS: 83397-56-2

Ref. 3D-IDA39756

10mgTo inquire
25mgTo inquire
50mgTo inquire
Estimated delivery in United States, on Friday 27 Dec 2024

Product Information

Name:
PL 017
Synonyms:
  • D-prolinamide, L-tyrosyl-L-prolyl-N-methyl-L-phenylalanyl-
  • Pl017
Description:

PL 017 is a synthetic delta-opioid that binds to kappa opioid receptors and inhibits voltage-dependent calcium channels. It has been shown to be effective in preventing restenosis by inhibiting platelet aggregation, which is the process of blood cells sticking together and forming clots. PL 017 also has an antinociceptive effect, which may be due to its membrane hyperpolarization effect and inhibition of adrenergic receptors. This drug can be used as a diagnostic tool for detecting receptor binding sites in cell cultures.
PL 017 has been shown to inhibit the binding of naloxone, which is an antagonist of opioid receptors, to the mu-opioid receptor by 50%. The molecular modeling technique was used to show that PL 017 binds with high affinity at the delta-opioid receptor site.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
535.6 g/mol
Formula:
C29H37N5O5
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-IDA39756 PL 017

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".